Article

Prediction of riboswitch as a potential drug target and design of its optimal inhibitors for Mycobacterium tuberculosis

2015-01-01

Abstract excerpt

Non-homologous proteins have been widely identified as major drug targets in host-parasite diseases like tuberculosis. The available antibiotic treatment for infectious diseases have suffered a major setback due to the development of drug resistance by the pathogen. Therefore, in the present study the riboswitch is explored as a promising alternative potential drug target. A framework has been developed for the pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1799292e-a20c-590a-bf15-1b43fba3db22
DOI: 10.1504/ijcbdd.2015.073671

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prediction of riboswitch as a potential drug target and design of its optimal inhibitors for Mycobacterium tuberculosisDOI 10.1504/ijcbdd.2015.073671Read

Exploration of potential inhibitors for tuberculosis via structure‐based drug design, molecular docking, and molecular dynamics simulation studiesSemantic proximity Read

“In-silico Prediction of Riboswitches and Design of their Potent Inhibitors for H1N1, H2N2 and H3N2 Strains of Influenza Virus”Semantic proximity Read

Hybrid dynamic pharmacophore models as effective tools to identify novel chemotypes for anti-TB inhibitor design: A case study with Mtb-DapBSemantic proximity Read

Hybrid Dynamic Pharmacophore Models as Effective Tools to Identify Novel Chemotypes for Anti-tb Inhibitor Design: a Case Study With Mtb-dapbSemantic proximity Read

Docking Molecular analysis of potential Drug Paritaprevir against Mycobacterium tuberculosis (Mtb)Semantic proximity Read

The design and synthesis of a new lead against tuberculosisSemantic proximity Read

Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential CandidatesSemantic proximity Read

Identification and Validation of Novel Drug Targets in TuberculosisSemantic proximity Read

Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.Semantic proximity Read

Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosisSemantic proximity Read

Computational approaches: Atom-based 3D-QSAR, molecular docking, ADME-Tox, MD simulation and DFT to find novel multi-targeted Anti-tubercular agentsSemantic proximity Read

Exploring natural products library to identify potential inhibitors targeting isoniazid-resistant tuberculosis.Semantic proximity Read